The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Cholesterol, LDL, LDL, LDL Cholesterol, Direct, Low Density Lipoprotein
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Lipoprotein A, Lp (a), Lp(a)
Also known as: Ion Mobility, Cardio IQ Lipoprotein Fractionation, Ion Mobility , HDL Subfractions, IDL Subfractions, LDL Subfractions, Lipoprotein Fraction, Lipoprotein Fractionation, Lipoprotein Fractionation Ion Mobility Cardio IQ, Quest Diagnostics has replaced the VAP® Cholesterol Test with Lipoprotein Fractionation, Ion Mobility, Cardio IQ™ test
Also known as: Very Low-Density Lipoprotein Cholesterol, VLDL, VLDL-C
The CVD-3. High Cholesterol Testing panel contains 8 tests with 22 biomarkers.
Brief Description: The CVD-3 High Cholesterol Testing panel is a thorough diagnostic tool aimed at evaluating cardiovascular health by examining a broad spectrum of lipid profiles, inflammatory markers, and other specific tests related to heart disease risk. This panel includes Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol. It's designed for a comprehensive assessment of cardiovascular risk factors, particularly for individuals at high risk or with existing cardiovascular conditions.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Fasting for at least 12 hours is required.
The CVD-3 High Cholesterol Testing panel is often recommended for individuals with known cardiovascular diseases, those with a family history of heart disease, or individuals who have multiple cardiovascular risk factors such as obesity, diabetes, hypertension, or smoking. It is also useful for patients whose treatment plans based on standard lipid panels require further refinement or those who need a deeper investigation into their cardiovascular health status.
Apolipoprotein A1: Measures the level of ApoA1, a major component of HDL cholesterol, helping to evaluate the body's ability to clear cholesterol from the bloodstream.
Apolipoprotein B: Assesses ApoB levels, found in LDL cholesterol, which can provide insight into the number of atherogenic particles in the blood.
Direct LDL: Offers a direct measurement of LDL cholesterol, bypassing the need for calculation based on other lipid levels, providing a more accurate assessment of LDL concentration, especially in cases with high triglycerides.
hs-CRP: A marker of inflammation that is associated with an increased risk for cardiovascular events. Elevated hs-CRP levels indicate higher levels of inflammation and potentially an increased risk of heart disease.
Lipid Panel with Ratios: A comprehensive assessment of cholesterol and triglycerides, including total cholesterol, HDL, LDL, and triglycerides, along with important ratios that help assess cardiovascular risk.
Lipoprotein (A): Measures levels of Lp(a), a lipoprotein that can contribute to atherosclerosis. Elevated Lp(a) levels are considered a risk factor for cardiovascular diseases.
Cardio IQ™ Lipoprotein Fractionation, Ion Mobility: Provides detailed information on the size and number of various cholesterol particles, offering insights into the risk of cardiovascular disease beyond traditional lipid measures.
LP PLA2 Activity: Measures the activity of Lp-PLA2, an enzyme associated with vascular inflammation and plaque instability, providing additional risk assessment for cardiovascular events.
VLDL Cholesterol: VLDL is a type of lipoprotein that primarily carries triglycerides. High levels can contribute to the development of plaque in the arteries, leading to cardiovascular diseases.
The CVD-4 High Cholesterol Testing Panel represents the pinnacle of cardiovascular diagnostics, expanding upon the CVD-3 panel by including the Cardio IQ™ ApoE Genotype test. This genetic test identifies variations in the ApoE gene, which can influence cholesterol metabolism and the body's response to dietary fats, providing a personalized approach to managing cardiovascular risk and tailoring treatment strategies.
The CVD-3 High Cholesterol Testing panel aids in the detection and management of:
Atherosclerotic Cardiovascular Disease: By providing a detailed lipid profile, including particle size and inflammatory markers, the panel helps in assessing the risk and guiding the management of conditions leading to plaque buildup in the arteries.
Inflammatory Heart Conditions: Elevated hs-CRP and LP PLA2 Activity levels indicate underlying inflammation that could contribute to heart disease, necessitating targeted interventions.
Healthcare professionals use the comprehensive data from the CVD-3 High Cholesterol Testing panel to:
Customize Treatment Plans: Detailed lipid profiles and inflammatory markers guide the selection of lipid-lowering therapies and anti-inflammatory treatments.
Monitor Disease Progression and Treatment Efficacy: Ongoing assessments with the CVD-3 panel can track changes in cardiovascular risk factors, adjusting treatments as necessary to optimize patient outcomes.
The CVD-3 High Cholesterol Testing panel offers an in-depth evaluation of cardiovascular risk factors, providing critical insights into lipid metabolism, inflammation, and genetic predispositions that influence heart health. This panel is an invaluable resource for individuals at risk of cardiovascular diseases, allowing for personalized treatment approaches and proactive management of heart health. For those seeking the most comprehensive assessment, the CVD-4 panel further enhances cardiovascular risk evaluation with genetic testing, offering a tailored approach to prevention and care.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.